Sartorius AG
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SARTF research report →
Companywww.sartorius.com
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services worldwide. The company offers biosensors and kits, compliance tools, systems software, label-free detection systems, and SPR systems; live-cell analysis systems, flow cytometry platform, and cell analysis reagents and consumables; and antibody and recombinant protein media, viral vaccines media, regenerative medicine media, general media, downstream buffer, microcarrier, and stem cell media and reagent products, as well as strong acids, bases, and alcohols and detergents. It also provides multi-parallel bioreactors, benchtop bioreactors, single-use bioreactors, stainless steel bioreactors, cell culture bioreactors, microbial bioreactors, and software apps for bioreactors; membranes, blotting products, filter papers, glass and quartz microfibre products, and filtration equipment; syringe filters; and filtration devices, ultrafiltration devices, sterile filtration devices, harvesting devices, analytical sample prep systems, buffer exchange systems, diagnostic sample prep systems, particle analysis systems, pharmaceutical filtration systems, protein DNA concentration systems, venting moisture barriers, clarification systems, buffer and media products, and membrane chromatography products.
- CEO
- Michael Grosse
- IPO
- 2010
- Employees
- 13,573
- HQ
- Göttingen, DE
Price Chart
Valuation
- Market Cap
- $14.05B
- P/E
- 96.77
- P/S
- 4.43
- P/B
- 5.77
- EV/EBITDA
- 19.52
- Div Yield
- 0.32%
Profitability
- Gross Margin
- 45.59%
- Op Margin
- 16.52%
- Net Margin
- 4.58%
- ROE
- 6.05%
- ROIC
- 4.61%
Growth & Income
- Revenue
- $3.54B · 4.62%
- Net Income
- $154.84M · 84.34%
- EPS
- $2.25 · 84.43%
- Op Income
- $651.16M
- FCF YoY
- -62.21%
Performance & Tape
- 52W High
- $226.33
- 52W Low
- $181.58
- 50D MA
- $221.78
- 200D MA
- $214.03
- Beta
- 1.40
- Avg Volume
- 3
Get TickerSpark's AI analysis on SARTF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SARTF Coverage
We haven't published any research on SARTF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SARTF Report →